A 45-year-old man with obesity and type 2 diabetes is found to have mildly elevated ALT and ultrasound evidence of hepatic steatosis consistent with non-alcoholic fatty liver disease (NAFLD). There is no cirrhosis. According to current recommendations, which intervention has the greatest evidence for improving hepatic steatosis?